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Abstract
Background: Enterococcus faecium is a leading cause of hospital-acquired infection, particularly in the
immunocompromised. Here, we use whole genome sequencing of E. faecium to study within-host evolution and
the transition from gut carriage to invasive disease.
Methods: We isolated and sequenced 180 E. faecium from four immunocompromised patients who developed
bloodstream infection during longitudinal surveillance of E. faecium in stool and their immediate environment.
Results: A phylogenetic tree based on single nucleotide polymorphisms (SNPs) in the core genome of the 180
isolates demonstrated several distinct clones. This was highly concordant with the population structure inferred by
Bayesian methods, which contained four main BAPS (Bayesian Analysis of Population Structure) groups. The
majority of isolates from each patient resided in a single group, but all four patients also carried minority
populations in stool from multiple phylogenetic groups. Bloodstream isolates from each case belonged to a single
BAPS group, which differed in all four patients. Analysis of 87 isolates (56 from blood) belonging to a single BAPS
group that were cultured from the same patient over 54 days identified 30 SNPs in the core genome (nine
intergenic, 13 non-synonymous, eight synonymous), and 250 accessory genes that were variably present.
Comparison of these genetic variants in blood isolates versus those from stool or environment did not identify any
variants associated with bloodstream infection. The substitution rate for these isolates was estimated to be 128
(95% confidence interval 79.82 181.77) mutations per genome per year, more than ten times higher than previous
estimates for E. faecium. Within-patient variation in vancomycin resistance associated with vanA was common and
could be explained by plasmid loss, or less often by transposon loss.
Conclusions: These findings demonstrate the diversity of E. faecium carriage by individual patients and significant
within-host diversity of E. faecium, but do not provide evidence for adaptive genetic variation associated with invasion.
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Background
Enterococcus faecium is a common gut commensal and a
leading cause of nosocomial infection, particularly in the
immunocompromised [1]. Bacterial characterisation
using multilocus sequence typing (MLST) has demon-
strated that hospital-adapted E. faecium are genetically
distinct from commensal isolates [2] and cluster within
clonal complex (CC) 17, now designated as clade A1 [3].
Isolates belonging to this clade are globally disseminated
and have been linked to numerous healthcare-associated
outbreaks [4–6]. Their enhanced biological fitness in
healthcare settings has been associated with genetic
adaptations that alter survival, virulence and antibiotic
resistance [1, 3, 7]. Vancomycin-resistant E. faecium
(VRE) is of particular concern and limits treatment
options [8, 9], as recognized by its inclusion in the
WHO priority pathogens list for the research and
development of new antibiotics [10].
The increasing application of whole genome sequencing
(WGS) to clinical settings has begun to elucidate the gen-
omic epidemiology of E. faecium at national and individual
hospital levels [11–13]. In addition to confirming the wide-
spread dissemination of hospital-acquired E. faecium, these
studies have shown that WGS can track VRE transmission
during complex healthcare pathways that involve multiple
wards within the same hospital [14]. Less is known about
the genomic dynamics and evolution of E. faecium within
individual patients [15]. This is important as there is
growing evidence that short-term within-host evolution is
higher than that estimated for long-term evolution and can
result in a divergent population [16], which can manifest as
variable drug resistance and virulence [17, 18]. One previ-
ous longitudinal study of E. faecium carriage by residents of
a nursing home described the presence of lineages that
varied in vancomycin resistance associated with loss of
vanA in the same individual [19]. Here, we extend these
findings through the study of four patients who developed
E. faecium bloodstream infection while undergoing longitu-
dinal surveillance of stool carriage, and from whom mul-
tiple colonies were sequenced from stool, blood cultures
and their environment.
Methods
Study setting and participants
Four patients were prospectively identified on two adult
haematology wards at the Cambridge University Hospitals
NHS Foundation Trust (CUH) between May and Nov
2015 (two cases on each ward) who developed E. faecium
bloodstream infection during longitudinal screening for E.
faecium carriage in stool on admission and weekly until
discharge. Blood cultures were taken by the treating
doctors following protocols for sepsis investigation. Blood
culture sets consisting of three bottles (standard aerobic,
anaerobic and FAN, BacT/ALERT, bioMérieux, Marcy
l’Etoile, France) were obtained peripherally and/or
centrally. Environmental samples were also obtained from
patient bedside and bathroom/toilet areas from three
cases on the day of discharge using flocked swabs
(FLOQSwabs, Copan Italia spa, Brescia, Italy).
Microbiology
Blood cultures were processed by the routine diagnostic
laboratory. For those positive for E. faecium, up to ten
colonies were randomly selected from each positive
blood culture set by picking colonies from all positive
primary plates onto which bottles were sub-cultured.
Environmental swabs were inoculated into Brain Heart
Infusion broth, incubated at 37 °C in air overnight and
100 μL sub-cultured onto BBLTM EnterococcoselTM agar
(BD, Oxford, UK) supplemented with 30 mg/L ampicillin
(Sigma-Aldrich, Poole, UK) to select for ampicillin-resistant
E. faecium), and Brilliance VRE (Oxoid, Basingstoke, UK)
to select for vancomycin-resistant E. faecium. A single
colony was selected from each environmental sample, with
priority given to vancomycin-resistant E. faecium if present.
Stool samples were cultured onto two solid media (Entero-
coccosel agar with ampicillin, and Brilliance VRE chromo-
genic agar) and into two enrichment broths (Enterococcosel
(BD, Oxford, UK) and Enterococcosel with 6 mg/L vanco-
mycin). In addition, the first stool sample for each patient
was cultured using media without antibiotic selection (Sla-
netz-Bartley agar (Oxoid), and Enterococcosel broth). Cul-
ture media and broths were incubated at 37 °C in air for up
to 48 h, with the addition of shaking for liquid culture. For
broths that turned black (indicative of enterococcal growth),
100 μL was sub-cultured onto Enterococcosel agar with/
without ampicillin or Brilliance VRE, respectively. Up to five
colonies were picked from each plate for confirmation of
species using matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS; Bioty-
per version 3.1, Bruker Daltonics, Coventry, UK). Pheno-
typic antimicrobial susceptibility testing was determined
using the P607 card on the Vitek 2 instrument (version 7.01,
bioMérieux, Marcy l’Étoile, France). Categorization into sus-
ceptible, intermediate and resistant was done according to
EUCAST clinical breakpoints (http://www.eucast.org/clini-
cal_breakpoints/) except for high-level gentamicin and high-
level streptomycin resistance, which were validated against
CLSI synergy testing (500 and 1000 mg/L, respectively).
Sequencing and population genomics analysis
DNA was extracted and DNA libraries prepared and se-
quenced on an Illumina HiSeq2000 with 100-cycle paired-
end runs as described previously [20] to give an average
depth of 85-fold. MLST sequence types (STs) were derived
from Illumina read data using the script available at https://
github.com/sanger-pathogens/mlst_check. A Velvet-based
algorithm [21] was used to produce de novo multi-contig
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assemblies, which were annotated with Prokka [22], and
the output used to reconstruct the pan-genome using
Roary [23]. A core genome was created for each isolate
using a 99% cut-off, with a default 95% identity cut-off. Sco-
ary [24] was used with 50 re-samplings in the permutation
test to find significant associations between the presence
and absence of genes in the pan-genome and antibiotic sus-
ceptible/resistant and carriage/disease phenotypes. Single
nucleotide polymorphisms (SNPs) were extracted from the
core-genome alignment produced by Roary using the script
available at https://github.com/sanger-pathogens/snp-sites.
Sites with ambiguous calls were removed and the output
used to construct a neighbour-joining phylogenetic tree
with the ape and phangorn packages in R. The tree and
associated metadata were visualised using iTOL [25] and
Figtree (http://tree.bio.ed.ac.uk/software/figtree/).
Population structure and phylogenetic Bayesian analysis
We used the core genome alignment produced by Roary
and extracted the SNPs with an in-house tool, available
at https://github.com/sanger-pathogens/snp-sites. We
then used the SNP presence or absence as the input for
Scoary to identify variants strongly associated with the
source of isolation. The SNP alignment was also used to
estimate the genetic population structure by hierBAPS
[26], which is a nested clustering approach, with five,
seven and ten values for estimated number of clusters
and two iterations. After identifying four BAPS clusters
that contained isolates associated with bloodstream
infection (referred to here as BAPS 1, 2, 3 and 4), a
Bayesian phylogenetic tree was obtained for isolates
within each group so as to obtain a more accurate
picture of recent evolution within each BAPS group. To
achieve this, the reads were first mapped to a nominated
reference sequence in each cluster based on the best
assembly statistics (largest N50 value). SMALT v0.7.4
(http://www.sanger.ac.uk/science/tools/smalt-0) was then
used on each cluster with the maximum and minimum in-
sert sizes of 1000 and 50, respectively. SAMtools mpileup
and BCFtools were used to detect SNPs, with the param-
eter values of a minimum base quality of 50 and minimum
root mean squared mapping of 30 to identify SNPs. SNPs
at sites in which the variant was present in < 75% of
paired-end reads were excluded. Mapping to a reference
genome can be inaccurate if the reference genome has a
different structure based on genomic re-arrangements or
other genetic variation. However, in our analysis the local
reference was highly similar to the other isolates within
the same BAPS group (>99% identity) and is unlikely to
have a significantly different genomic architecture.
We then used Gubbins [27] with five iterations to remove
high SNP density regions, which are indicative of recombin-
ation. To assess the temporal signal for each cluster, the
root-to-tip distance values obtained by constructing a
neighbour-joining tree was plotted against time (day) of iso-
lation, using 10,000 bootstraps with re-sampled days to at-
tain a distribution for R-squared values. The significance of
the real R-squared was evaluated based on the distribution.
BEAST v1.7 [28] was then used on the SNP alignment
to obtain the Bayesian tree. Isolates were assigned based
on the sample from which each was cultured (blood
culture, stool or environmental sampling), which were
defined as a discrete “source” trait and then used to
reconstruct the counts of state change, as detailed in
[29]. BEAST was run using date of isolation and various
models that included a strict molecular clock model with
uniform and lognormal distribution for base frequency
and a lognormal distribution for the transition of loca-
tion status. Three independent MCMC chains were run
for 50 million generations (sampling every 1000 genera-
tions). The convergence was confirmed if the effective
sample size exceeded 200, after excluding the first 10%
states as burn-in. The TreeAnnotator tool, which is part
of the BEAST package, was then used to obtain confi-
dence intervals for the node ages. The key parameters,
including tree root height and clock rate, of different
runs from different models were in agreement.
Using the alignment from the Bayesian analysis, the
SeqTrack function in the Adegenet R package was used
to construct a network for within-host isolates for each
BAPS cluster. This reconstructs the most parsimonious
network structure based on pairwise SNP distances and
date of isolation [30, 31]. The results were visualized
using functions in the igraph package in R.
The marginal likelihood values for the ancestral state
for presence/absence of plasmids were estimated with
the rerootingMethod function (the SYM function) in the
phytools R package. The results were then displayed
with the plotTree function.
Identification of virulence factors, antibiotic resistance
and plasmids
Virulence factors, resistance genes and plasmid replicons
were identified using the srst2 package [32] using 90%
coverage and 10% divergence cut-offs. Virulence factors
were curated by extracting known and putative virulence
factors for E. faecium from multiple sources, including the
virulence factor database (http://www.mgc.ac.cn/VFs/).
The list of virulence factors is available in Additional file 1.
The plasmid replicon database and antibiotic resistance
genes were downloaded from the srst2 package. The pres-
ence of plasmids was further evaluated by reconstructing
plasmid assemblies using plasmidSPAdes [33], based on
their coverage. After confirming the presence of a plasmid,
the genomic context of resistance genes was confirmed by
comparing the plasmid containing the gene of interest
against the non-redundant nucleotide NCBI database
using BLAST. Paired-end reads were then mapped to the
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reference genome of known previously sequenced plas-
mids using the same approach as above to confirm the
presence of the plasmid. The sequence and the annotation
files of the plasmid in BAPS2 group, reported in [14], are
available in Additional file 2.
Results
Our analysis was based on the whole genomes of 180 E.
faecium isolates cultured from the blood and stool of four
hospital in-patients (termed patients A–D) and the
environment of three of these cases (see Additional file 3:
Figure S1 for sampling timeline). To define the population
diversity of the entire collection, a phylogenetic tree was
constructed based on SNPs in the core genome (Fig. 1a).
This demonstrated several distinct clones, which were
highly concordant with the population structure inferred
by hierBAPS (Fig. 1a). Four different BAPS groups
(termed 1–4) contained isolates associated with blood-
stream infection (Fig. 1a, c). Although the majority of iso-
lates from each patient resided in a single BAPS group,
the four patients also carried minority populations in stool
that belonged to multiple BAPS groups, a diversity that
was maintained over time (Additional file 3: Figure S2).
Bloodstream isolates from each patient belonged to a
single BAPS group that differed in each individual (Fig. 1a,
b). BAPS1, BAPS2, BAPS3 and BAPS4 contained blood
isolates from patient A, B, C and D, respectively. Blood-
stream isolates in some patients were related to stool
carriage isolates from other cases (Fig. 1a, b). Specifically,
stool isolates from patient B resided in BAPS1 group that
contained blood isolates from patient A. Furthermore, an-
other stool isolate from patient B together with an envir-
onmental isolate from patient D resided in the same BAPS
group as blood isolates from patient C (Fig. 1b). These
findings suggest that isolates from bloodstream infections
are closely linked with carriage isolates, which may be
shared by different patients.
Multilocus sequence types (STs) were derived from the
sequence data for the isolate collection. This revealed
multiple STs, the majority of which were ST80 (n = 136)
with the remainder being ST262 (n = 10), ST78 (n = 26)
and ST280 (n = 4), all of which belong to the hospital-
associated clade A1 (CC17), together with two isolates
with novel STs (Fig. 1a). To confirm the clade assign-
ment for the study isolates we compared these with the
genomes of isolates from A1, A2 and B clade drawn
a b
c
Fig. 1 a Neighbour-joining tree of 180 E. faecium genomes used in this study. BAPS clusters 1, 2, 3 and 4 are inferred BAPS groups that all con-
tained invasive isolates. The pie charts for BAPS groups 1, 2, 3 and 4 contain 13, 87, 26 and 26 isolates, respectively. The BAPS groups were on
average 4797.97 SNPs apart. The average pairwise SNP distance for isolates within BAPS1, 2, 3 and 4 were 3.97, 2.13, 2.86 and 1.30, respectively.
The BAPS run columns correspond to clustering results with five and ten values for the estimated numbers of clusters in the hierBAPS analysis.
Each colour signifies one group. BAPS groups 1, 2, 3 and 4, which contained invasive isolates, were inferred with both parameter sets. The root of
the tree is the midpoint of the two most distant taxa in the collection. Frequency of isolates based on patient (b) and source of isolation (c)
across four BAPS groups
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from a diverse collection described previously [3], which
were recovered from various ecological environments.
The phylogenetic tree of isolates constructed from the
core genome confirmed that our isolates resided in clade
A1 (Additional file 3: Figure S3). We noted that STs had
poor resolution in capturing the within-patient popula-
tion diversity, with incomplete concordance between the
ST tree and whole genome tree (see ST80 clades in
Fig. 1a), which can be attributed to recombination in
MLST loci. This indicates the superiority of WGS in
understanding fine resolution of within-host population
structure, as described previously [12, 34].
For the analysis of within-host bacterial diversity, we
first examined isolates from patient B who had 102 iso-
lates (56 blood, 38 stool, eight environmental) recovered
from 22 specimens (eight blood, six stool, eight environ-
mental) over a period of 54 days, including a period of
persistent bacteraemia over 9 days (Additional file 3:
Figure S1). Phylogenetic analysis of the 102 isolates
demonstrated that most isolates resided in BAPS2 (56
blood, 25 stool, six environmental), and were assigned to
ST80, ST262 and ST78, which were each distributed
across the tree (Fig. 1). The stool E. faecium population
was assigned to BAPS1, BAPS2 and additional minor
groups (Additional file 3: Figure S2). Despite the pres-
ence of multiple strain types in stool, only ST80/BAPS2
isolates from stool were closely related to isolates
cultured from blood (Fig. 1a). These were present in
stool before the first episode of bacteraemia, suggesting
that the patient developed invasive disease with their
carriage isolate (Fig. 1a; Additional file 3: Figure S2). A
more detailed analysis of diversity in BAPS2 was under-
taken to explore whether one or more genetic features
were over-represented in invasive isolates and could be
associated with the process of invasion or survival in the
bloodstream. This included an analysis of mutations and
the presence/absence of accessory genes. SNPs were
identified in patient B/BAPS2 isolate genomes by
mapping to a relevant reference genome and removing
hypervariable recombinant regions (Fig. 2; Additional
file 4). This identified 30 SNPs, of which nine were inter-
genic, 13 were non-synonymous and eight were syn-
onymous. The non-synonymous mutations occurred in
regulator proteins, ABC transporters and putative mem-
brane proteins. A pan-genome analysis identified 250
accessory genes (~ 7% of the pan-genome) that were
variable in patient B BAPS2 isolates (Additional file 5).
This included genes carried by the plasmid that also
carried vancomycin resistance genes (see below). The other
genes were mainly insertion elements, phage-related and
hypothetical proteins. Comparison of the presence of SNPs
or accessory genes in blood versus other isolates, including
environmental and stool isolates, did not reveal an associ-
ation between the presence/absence of either an accessory
gene or SNP and blood isolates (Additional file 3: Figure
S4). This suggests that invasion was not linked with a
particular adaptive variant.
We noted that patient B BAPS2 isolates had a strong
temporal signal (R-squared value for the dataset was
greater than those of 99% of replicas in the bootstrap
test) and used Bayesian analysis to further explore
within-host population diversity over time in this patient
(Fig. 2). The substitution rate calculated for within-host
E. faecium evolution was 128 (95% confidence interval
(CI) 79.82 181.77) mutations per genome per year, which
is more than ten times higher than previous estimates
for E. faecium based on a collection of clinical isolates in
which each isolate was from a different patient [14]. This
discrepancy is consistent with previous suggestions that
within-patient substitution rates are higher due to
increased genetic drift and limited time for purifying
selection to act on mildly deleterious mutations [16].
We repeated the Bayesian analysis for a subset of 20 iso-
lates drawn from the four BAPS groups, i.e. five isolates
from each BAPS group, for all four patients and found a
lower substitution rate of 18.25 (95% CI 11.52 45.63)
mutations per genome per year, which is closer to
previous estimates [14, 35]. Due to the low number of
variants within the BAPS groups, a comparison between
strength of selection within and across lineages was not
possible, but we identified a total of 678 variants (120
intergenic, 187 synonymous, 371 non-synonymous) that
were fixed in the lineages across BAPS groups (Additional
file 6). The non-synonymous variants occurred in different
functional groups of genes, including membrane proteins,
surface proteins, including transporters and facilitators,
and regulatory genes. Whether or not these variants
contain any adaptive significance needs verification from
experimental functional studies.
The phylogenetic tree of patient B BAPS2 isolates
demonstrated some mixing of blood, stool and environ-
mental isolates but was consistent with stool isolates
being ancestral to those isolated from blood as well as
later isolates from stool and the environment (Fig. 2).
Stool to blood transition could also be inferred from a
transmission network reconstructed for BAPS2 isolates,
which indicated high connectivity between stool, blood
and environmental isolates (Fig. 3). In the network,
carriage isolates gave rise to multiple blood isolates,
some of which were closely linked with other stool and
environmental isolates. This is consistent with the
possible repeated translocation of E. faecium from
gut into blood (Fig. 3). Both the transmission
network and the phylogenetic tree included cases
where blood isolates appeared to be ancestral to
stool and environmental isolates; this is likely to be
due to the presence of ancestral stool isolates that
were not sampled.
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Fig. 2 Bayesian phylogenetic tree for patient B/BAPS2 group. Branches and nodes are coloured based on the inferred origin of ancestral strains.
The size of the diamond signs shows the posterior probability values for the inferred status. The bars on the nodes denote 95% confidence
intervals, i.e. the credible set that contains 95% of the sampled values
Fig. 3 Transmission tree of BAPS2 isolates from three patients reconstructed based on genetic distance and isolate dates. The edge numbers
denote the number of mutations. Arrows model potential transmissions from ancestors
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The presence of antibiotic resistance genes was
mapped across the isolate collection from all four cases.
This revealed a high degree of lineage specificity, with
little variation within specific BAPS groups (Fig. 4). Only
vancomycin resistance genes and dfr were variably
present in closely related blood, stool and environmental
isolates in BAPS2 (Fig. 4). Consideration of within-host
isolate resistance was focused on the largest subset from
patient B, who carried isolates in stool that were variably
resistant to streptomycin, gentamicin and quinupristin/
dalfopristin. These resided in different BAPS groups, but
BAPS2 blood isolates were universally resistant to
streptomycin but susceptible to gentamicin and quinu-
pristin/dalfopristin (Fig. 5). By contrast, patient B BAPS2
isolates were variably resistant to vancomycin and teico-
planin (Fig. 5). To explore this further, we determined
the genomic context of vancomycin resistance genes and
the presence of transposon Tn1546. This demonstrated
that the transposon was carried by a plasmid with the
same backbone described previously in E. faecium
isolates associated with bacteraemia at the same study
hospital [14]. The van genes and associated plasmid
were present in ancestral stool isolates but were absent
in multiple strains that were recovered later (Additional
file 4: Figures S5 and S6). The uncertainty about the
status of the ancestral stool isolates, in terms of the
presence of the plasmid and the resistance gene, suggests
that the population initially contained a mixture of vanco-
mycin susceptible and resistant isolates and that the initial
bacteraemia isolates were all susceptible (Additional file 3:
Figure S6). Strikingly, under vancomycin treatment, both
the stool and the bloodstream population of E. faecium
shifted to vancomycin-resistant strains. Thirty-six days after
vancomycin treatment was discontinued, a susceptible
population of E. faecium was again detectable in stool. The
findings suggest a dynamic balance between vancomycin-
resistant and susceptible E. faecium sub-populations where
plasmid or van genes can be lost in some stool isolates in
the absence of antibiotic treatment, but the resistant sub-
population is maintained and selected under antibiotic
pressure (Additional file 3: Figure S6).
Analysis of within-host diversity in the three other cases
revealed several similarities and some differences compared
with patient B. For instance, patient A isolates (n = 22: ten
blood, 12 stool) had stool isolates that resided in three dif-
ferent clades (Fig. 1a). A single stool isolate in BAPS1 was
genetically mixed with, and was on average 2.5 SNPs differ-
ent from, the blood isolates (Additional file 3: Figure S7).
Blood and stool isolates from patient A were also related to
stool isolates from patient B, which were ancestral and had
an average SNP distance of ~ 116 SNPs. All patient A blood
isolates were vancomycin resistant due to vanA carried by
the plasmid identified in patient B isolates (results not
shown). We identified 221 accessory genes that were
Fig. 4 Phylogenetic distribution of genes encoding antibiotic resistance and virulence factors. Note that only virulence factors that were variably
present in the population are shown, meaning that some of the well-known virulence factors, e.g. sagA and atlAEfm, present in every isolate are
not shown. The sequence file for the virulence factors studied here is provided in Additional file 1. Note that the vanB-containing isolate was
phenotypically susceptible to vancomycin due to lack of vanRB and vanSB
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variably present in patient A isolates within the BAPS1
group. The stool isolate appeared to lack fms20 encoding a
cell surface protein (Additional file 5). To address whether
or not the gene confers adaptive importance would require
experimental verification, although we note that this gene
was not differentially distributed in blood and stool isolates
from other patients.
Patient C isolates (n = 29: ten blood, 15 stool, four envir-
onment) resided across three clades in the phylogenetic
tree (Fig. 1a; Additional file 3: Figures S1 and S2). The
majority (24/29) resided in BAPS3, which also contained
an isolate from the environment of patient D and a stool
isolate from patient B, which were ancestral to those from
patient A (Fig. 1b; Additional file 3: Figure S7). In the
phylogenetic tree, blood isolates formed a single clade that
originated from ancestral stool isolates, and there was an
indication of single or multiple introductions of isolates
from stool into the environment (Additional file 4: Figure
S6), the transmission network confirming that stool
isolates served as sources for blood and environmental
isolates (Fig. 3). Except for one environmental isolate, the
other isolates in BAPS3 from patient A were vancomycin
resistant and had a vancomycin resistance transposon
inserted into the backbone of the same plasmid as the
patient B isolates. A set of 68 accessory genes, mainly
mobile genetic elements, were variably present in patient
C isolates within BAPS3 (Additional file 6). In addition,
eight non-synonymous, seven synonymous and four
intergenic mutations and two indels were identified
(Additional file 5). None of these were associated with
source of isolation.
Patient D isolates (n = 27: 20 blood, two environmental,
five stool) resided in two BAPS groups. The majority (26)
clustered in BAPS4 and differed by nine SNPs (three non-
synonymous, two synonymous and four intergenic), while
the remaining isolate resided with isolates from patient C
in BAPS3 (Fig. 1; Additional file 3: Figure S7). In contrast
to other patients, E. faecium was not recovered from stool
obtained 9 and 5 days prior to the onset of bacteraemia
but blood isolates clustered with stool and environmental
isolates cultured subsequently (Additional file 3: Figure
S7). The van genes resided on a different plasmid to the
other cases, the plasmid backbone contained a replicon
recovered previously from an individual in New York,
USA (plasmid accession ID CP018831) [36], our data
showing 68% coverage of that plasmid. One blood isolate
was vancomycin susceptible and lacked the whole
plasmid, including the resistance gene (Additional file 3:
Figure S7). We identified 147 accessory genes, some of
which were plasmid related and included vancomycin re-
sistance genes (Additional file 6).
The association between source of isolation and varia-
tions in SNPs and accessory genes was also assessed for
the isolates from all four patients using Scoary (see
“Methods”). However, no variant was identified that was
associated with source of isolation.
We screened the collection for specific virulence genes
(Additional file 7), the majority of which were present in
Fig. 5 Frequency of resistant and susceptible isolates across the phylogenetic tree for antibiotics tested in this study
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every isolate or were lineage specific and not linked with
the origin of isolates (blood versus stool) (Fig. 4). We
detected variability in the presence of gls genes (glsA and
glsB), which are involved in bile resistance and are
crucial for adaptation to the intestinal environment [37],
but these were not over-represented in invasive iso-
lates compared with isolates from stool (for example,
present in 48 and 52% of the blood and stool isolates
in BAPS2, respectively).
Discussion
We utilized WGS to characterize E. faecium associated
with stool carriage and bloodstream infection in four
patients over time. Each patient carried several distinct
clades in their stool, but only one of these was isolated
from blood in each case. In the overall collection, BAPS
groups containing blood isolates also contained stool
and environmental isolates, indicating that the diversity
of invasive isolates is part of the broader diversity of the
carriage population, and that isolates from the immedi-
ate environment were derived from carriage. A compara-
tive genomic analysis of related isolates in stool and
blood of the same patient failed to reveal adaptive muta-
tions associated with invasive disease. This is consistent
with the opportunistic nature of infection in haemato-
oncology patients who have numerous risk factors for
systemic infection, including the presence of intravascu-
lar and urinary catheters, neutropaenia and loss of
mucosal barrier integrity. We found that sub-populations
of nearly identical isolates at the core genome differed in
the presence of van genes with evidence of loss of the van
transposon and/or the plasmid, suggesting instability.
However, the maintenance of a resistant sub-population is
crucial for its survival under antibiotic pressure and can
result in a rapid shift towards its dominance in both the
stool and the bloodstream.
We estimated a higher substitution rate for within-
host isolates than has previously been calculated for E.
faecium from population studies. A higher substitution
rate for within-patient diversity is not limited to E.
faecium and has been reported for other major pathogens
such as Helicobacter pylori and methicillin-resistant
Staphylococcus aureus (MRSA), and attributed to factors
such as increased drift within patients, enhanced by popu-
lation compartmentalization, repeated selective sweeps
and fluctuation in population size, along with limited time
for removal of mildly deleterious mutations [16].
The lack of adaptive genetic changes associated with
the carriage-invasive transition contrasts with the
within-host analysis of other pathogens such as MRSA,
where the transition of carriage to invasive status has
been linked with the emergence of multiple adaptive
mutations that result in truncated proteins [18]. Several
explanations are possible for the lack of evidence for
adaptive changes allowing invasion in E. faecium. Our
study patients were receiving treatment for haemato-
logical malignancy and so were immunocompromised,
had reduced integrity of mucosal barriers, intravenous
devices and repeated exposure to antibiotics. Such
circumstances are associated with colonization by drug-
resistant bacteria, and translocation of bacteria from the
gut into the bloodstream [38]. It is also the case that
hospital-adapted E. faecium belonging to CC17 have
acquired a genetic repertoire associated with persistence
and nosocomial infection, a pre-adaption that may be
sufficient to facilitate invasive disease [2, 39]. Although
our study systematically studied E. faecium recovered
from the stool and blood of patients over time, our cases
were restricted to patients who were immunocomprom-
ised, and only a small number were studied. This is a
potential limitation of the study, and invasive disease in
people who are immunocompetent may still be associ-
ated with specific adaptive bacterial changes, which
could be discovered with a larger sample size. A larger
dataset and more comprehensive screening are required
to determine whether the findings described here can be
more widely generalized.
Our study adds to previous evidence for the carriage of
numerous E. faecium lineages by hospitalized patients,
and the value of using genome sequencing to detect this
[14]. This means that picking a single bacterial colony
from a sample for sequencing to determine the genetics of
E. faecium carriage is likely to capture the dominant clade
but will overlook minor lineages, which nonetheless could
be associated with transmission and environmental con-
tamination. We found evidence for considerable sharing
of highly related isolates between stool and the environ-
ment of the same patient, which is consistent with envir-
onmental contamination. We also found sharing of highly
related isolates between the four cases, which extends
findings from a previous study in the same hospital of E.
faecium transmission associated with E. faecium blood-
stream infection [14].
Conclusions
Sequencing of numerous E. faecium isolates from four
patients over a period during which they developed
bloodstream infection has indicated that opportunistic
infection is not associated with bacterial adaptation for
the transition from carriage to the invasive disease state.
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